Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > CG0070 + Pembrolizumab...Not even close to TLT-Ruvidar.

<< Previous

Bullboard Posts

Next >>

Comment by Dumbeldorfwhiteon Dec 14, 2023 11:41am

187 Views

Post# 35784564

RE:RE:CG0070 + Pembrolizumab...Not even close to TLT-Ruvidar.

Ya ‘ll keep sippin the look aid, 70%> 40%

Having those exclusions sure didn't seem to hurt enrollment they got 100 patients wayyyyyyy faster.
At the current enrollment rates u guys do realize it's going to take around 2 more years simply to have 100 people, then another 1.5 years to have all the data. how is this company going to survive raising 1 million every other month?

<< Previous

Bullboard Posts

Next >>

AI companies to invest in